Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-06-12T10:49:56.105Z

AK105-304

AK105-304
Nasopharynx cancer

A Randomized, Double blind, Multi center Phase III Study of Penpulimab (AK105) Combined with Chemotherapy versus Placebo Combined with Chemotherapy as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

A Randomized, Double blind, Multi center Phase III Study of Penpulimab (AK105) Combined with Chemotherapy versus Placebo Combined with Chemotherapy as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Nasopharynx

Study Phase

III

Trial Identifiers

Registration number: NCT04974398

https://clinicaltrials.gov/study/NCT04974398

GenesisCare Location(s)

GenesisCare North Shore 

 

GenesisCare North Shore    :::
Principal Investigator(s)

Dr Adrian Lee

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.